Study Group: Oncologists who Treat RCC (EU)

Council Members in this Study Group: 70

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Rossana Berardi, Consultant Medical Oncologist, UNIVERSITA' POLITECNICA DELLE MARCHERossana Berardi

Consultant Medical Oncologist
UNIVERSITA' POLITECNICA DELLE MARCHE
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Rossana Berardi, MD, is a Consultant Medical Oncologist and Lecturer at University Hospital. She is also responsible for the Trial Unit in the Department of Oncology at the Universita Politecnica delle Marche, Italy. Dr. Berardi usually deals with about...

15 news post(s)
Federica Bertolini

Medical Oncologist and Researcher
UNIVERSITA' DEGLI STUDI DI MODENA E REGGIO EMILIA
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Federica Bertolini, MD, is a Medical Oncologist and Researcher in the Division of GI Medical Oncology at Policlinico di Modena at the University Of Modena and Reggio Emilia. Dr. Bertolini has expertise in treatment of all gastro-intestinal tumors such...

Pedro Gascon

Director of Medical Oncology
HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Pedro Gascon, MD, PhD, is the Director of Medical Oncology and Scientific Coordinator of the Hematology-Oncology Department at Hospital Clinic Barcelona, Spain. Dr. Gascon is board certified in Internal Medicine, Hematology, and Medical Oncology, and...

Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Government/Military Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Facility, Academic Medical Center

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Division Head
  • Director
  • Physician - Director
  • Owner

Related Study Groups

Study Group Name No. Members
Oncologists (Spain) 33
Urologists who Perform Procedures Using the Da Vinci Surgical System 77
Council Members who Purchase the Da Vinci Robotic System 148
Neupogen Prescribers for Neutropenia 53
Oncologists (Germany, France, Italy) 352
Council Members who Treat Colon/Colorectal Cancer 274
Hematologist who treat patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) 84
Pulmonologists (EU) 257